12/04/2024 Edison: Funding accelerates Tedopi clinical development:
19/03/2024 Edison: One step closer to key data readouts:
28/02/2024 Edison: Confidence boost with AbbVie partnership:
22/01/2024 Edison - Clinical update, Active year ahead for proprietary programmes:
19/01/2024 Kepler Cheuvreux: Exciting 2024 Outlook:
12/12/2023 Edison - Clinical Update:
27/11/2023 Edison - Collaboration Update:
23/11/2023 Invest Securities - Test compagnon pour TEDOPI développé par EUROBIO:
17/10/2023 OSE Immunotherapeutics — Anticipation builds with positive OSE-279 data:
17/10/2023 Invest Securities - Pas d'impact attendu sur le burn rate avec la PH III:
28/09/2023 Invest Securities - Extension de la ligne de financement VESTER FINANCE:
13/09/2023 Invest Securities - Un rappel médiatique qui fait du bien à Tedopi®:
03/08/2023 EDISON - Operational Update:
06/07/2023 INVEST SECURITIES - FLASH OSE IMMUNO:
06/07/2023 EDISON - Regulatory Update:
05/07/2023 EDISON - Regulatory Update:
27/06/2023 INVEST SECURITIES - FLASH OSE IMMUNO:
26/06/2023 EDISON - Funding Update: